ConforMIS is a privately held medical device company developing personalized, patient-specific implants and instrumentation for knee-related therapeutics. The Company transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related image-to-implant technology platforms. Both platforms are supported by proprietary, intellectual property consisting and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems. To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery.

Type
Public
HQ
Bedford, US
Founded
2004
Size (employees)
383 (est)
ConforMIS was founded in 2004 and is headquartered in Bedford, US
Report incorrect company information

Key People/Management at ConforMIS

Amita Shah

Amita Shah

Vice President, Regulatory and Quality Affairs
John Slamin

John Slamin

Senior Vice President, Knee Implant Engineering
David Cerveny

David Cerveny

Senior Vice President, Intellectual Property & General Counsel
Adam Hayden

Adam Hayden

Vice President, Marketing

ConforMIS Office Locations

ConforMIS has an office in Bedford
Bedford, US (HQ)
28 Crosby Dr
Show all (1)
Report incorrect company information

ConforMIS Financials and Metrics

ConforMIS Financials

ConforMIS's revenue was reported to be $78.12 m in FY, 2017
USD

Revenue (FY, 2017)

78.1 m

Gross profit (FY, 2017)

28.8 m

Gross profit margin (FY, 2017), %

36.9%

Net income (FY, 2017)

(53.6 m)

EBIT (FY, 2017)

(55.8 m)

Market capitalization (20-Apr-2018)

77.3 m

Cash (31-Dec-2017)

18.3 m
ConforMIS's current market capitalization is $77.3 m.
Annual
USDFY, 2015FY, 2016FY, 2017

Revenue

66.9 m79.9 m78.1 m

Revenue growth, %

19%

Cost of goods sold

42.4 m53.2 m49.3 m

Gross profit

24.5 m26.7 m28.8 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

19.2 m13.9 m20.3 m19.3 m18.6 m20.5 m18.5 m

Cost of goods sold

10.7 m10.3 m13.2 m13.3 m12.6 m14 m12.2 m

Gross profit

8.6 m3.6 m7 m6 m6 m6.5 m6.2 m

Gross profit Margin, %

45%26%35%31%32%32%34%
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

117.2 m37.3 m18.3 m

Accounts Receivable

14.9 m14.7 m13.2 m

Inventories

11.5 m11.7 m9.2 m

Current Assets

146 m95.8 m69.9 m
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

14.5 m139.2 m76.6 m37.8 m35 m36.4 m39.2 m

Accounts Receivable

11 m8.3 m13.5 m13.1 m13.8 m13.1 m11.9 m

Inventories

9.4 m10.7 m11.9 m12 m11.8 m11.4 m11.8 m

Current Assets

40.8 m160.3 m130.9 m109.4 m101.2 m91.6 m94.7 m
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(57.2 m)(57.6 m)(53.6 m)

Depreciation and Amortization

2.6 m3.2 m3.7 m

Inventories

(3.8 m)(200 k)2.5 m

Accounts Payable

(8.7 m)(1.4 m)
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(25.1 m)(42.3 m)(15 m)(29.1 m)(41.8 m)(17.2 m)(29.3 m)

Depreciation and Amortization

1.2 m1.9 m734 k1.5 m2.3 m843 k1.7 m

Inventories

(1.7 m)(3 m)(399 k)(457 k)(235 k)337 k(64 k)

Cash From Operating Activities

(21.4 m)(33.5 m)(11.3 m)(27 m)(36.8 m)(11.3 m)(21 m)
USDY, 2017

Revenue/Employee

204 k

Financial Leverage

2 x
Show all financial metrics
Report incorrect company information

ConforMIS News and Updates

Knee Replacement Market 2018 – Higher ROI of the Medical Devices Sector will Trigger Investment

In the coming years, it is expected that the Global Knee Replacement Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Knee Replacement market. Posted via Industry Today. Follow us on Twitter …
Report incorrect company information